Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Linda T. Vahdat, MD

Advertisement

Articles by Linda T. Vahdat, MD

Dr. Vahdat Discusses the Side Effects of Halaven

ByLinda T. Vahdat, MD
January 18th 2012

Dr. Linda Vahdat, from New York-Presbyterian Hospital, Discusses the Side Effects of Halaven

Dr. Vahdat Compares Halaven and Ixempra Neuropathy

ByLinda T. Vahdat, MD
December 22nd 2011

Dr. Linda Vahdat, from the New York-Presbyterian Hospital, Compares Halaven and Ixempra Neuropathy

Advertisement

Latest Updated Articles

  • Dr. Vahdat Compares Halaven and Ixempra Neuropathy
    Dr. Vahdat Compares Halaven and Ixempra Neuropathy

    December 22nd 2011

  • Dr. Vahdat Discusses the Side Effects of Halaven
    Dr. Vahdat Discusses the Side Effects of Halaven

    January 18th 2012



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated, ER-Positive, HER2-Negative Advanced Breast Cancer

2

Recognizing and Evaluating Diarrhea in Metastatic Triple-Negative Breast Cancer

3

WCLC 2026: Oncology Nursing Takeaways on Supportive Care and APP-Led Models

4

Gynecologic Cancer Awareness: Dr. Teplinsky Discusses Nursing Roles

5

Patient Education for Gastrointestinal Toxicity in Metastatic Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us